Zevra Therapeutics, Inc. Stock Split Ratio
Zevra Therapeutics, Inc. (ZVRA) reported Stock Split Ratio of 13.00% for the 1-month period ending 2015-04-30, per its 10-Q filed 2015-11-13.
Discontinued › Notes › Equity
us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 · last filed 2017-05-22
- 2015-04-30: Stockholders' Equity Note, Stock Split, Conversion Ratio 1 month 13.00%.
- 2015-04-02: Stockholders' Equity Note, Stock Split, Conversion Ratio 0 month 13.00%; Stockholders' Equity Note, Stock Split, Conversion Ratio 750.00%.
| Period end | Stockholders' Equity Note, Stock Split, Conversion Ratio 0 month | Stockholders' Equity Note, Stock Split, Conversion Ratio | Stockholders' Equity Note, Stock Split, Conversion Ratio 1 month |
|---|---|---|---|
| 2015-04-30 | 13.00% 10-Q · filed 2015-11-13 | ||
| 2015-04-02 | 13.00% 10-Q · filed 2016-05-13 | 750.00% 10-Q · filed 2017-05-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |